Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.9% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
0
users have commented on this narrative
34
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
12
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.0% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Lantheus Holdings
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
PSMA PET Pricing Will Erode Margins Despite Diversification
Key Takeaways Pricing pressures, reimbursement challenges, and reliance on a few key products heighten risk of margin compression and revenue volatility. Product pipeline and partnerships offer diversification potential, but integration hurdles and regulatory headwinds may limit growth and profitability.
View narrative
US$70.00
FV
23.2% undervalued
intrinsic discount
3.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Trex Company
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Residential Decking Reliance And Rising Costs Will Limit Prospects
Key Takeaways Heavy reliance on residential decking and undiversified product lines leave the company exposed to housing market cycles and demographic challenges. Tightening sustainability regulations, volatile input costs, and intensifying competition threaten margins and the long-term viability of the business model.
View narrative
US$54.50
FV
20.8% overvalued
intrinsic discount
8.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Talen Energy
AN
AnalystLowTarget
Consensus Narrative from 13 Analysts
Decarbonization Pressures Will Erode Legacy Fossil Assets
Key Takeaways Heavy reliance on natural gas and conventional assets heightens exposure to decarbonization, regulatory, and market risks, potentially eroding market share and compressing revenue. Rising competition from renewables and decentralized energy could undermine core operations, reduce contract values, and further pressure earnings and asset values.
View narrative
US$279.68
FV
36.0% overvalued
intrinsic discount
9.87%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Informatica
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Cloud Consolidation Will Pressure Revenues Despite AI Potential
Key Takeaways Intensifying competition from cloud giants, open-source, and AI-driven solutions is eroding Informatica's pricing power, market share, and ability to differentiate its offerings. Rising regulatory and compliance challenges are driving up costs, threatening profitability and limiting the company’s potential for international expansion and earnings growth.
View narrative
US$19.90
FV
24.3% overvalued
intrinsic discount
3.75%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Exelixis
AN
AnalystLowTarget
Consensus Narrative from 19 Analysts
Regulatory Uncertainty And 340B Pressures Will Erode Oncology Margins
Key Takeaways Increasing regulatory scrutiny, payer discounts, and reliance on a single franchise threaten margins, revenue stability, and overall profitability. Rising R&D costs and intensifying competition in oncology create risks to market share, product relevance, and sustained earnings growth.
View narrative
US$36.00
FV
6.9% overvalued
intrinsic discount
4.52%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
5 days ago
author updated this narrative
Halozyme Therapeutics
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Biosimilar Competition And Pricing Pressures Will Erode Biologic Margins
Key Takeaways Heavy dependence on ENHANZE exposes the company to heightened risk from patent expirations, competition, and industry shifts in drug delivery technologies. Intensifying pricing pressure and pharma sector consolidation threaten future profitability, reducing the value of licensing deals and eroding recurring earnings.
View narrative
US$51.00
FV
27.7% overvalued
intrinsic discount
14.43%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Cirrus Logic
AN
AnalystLowTarget
Consensus Narrative from 6 Analysts
Smartphone Exposure And Escalating Tensions Will Compress Margins
Key Takeaways Heavy reliance on major smartphone customers and slow diversification leaves the company vulnerable to fluctuating device demand and stalled long-term growth. Rising industry competition, higher input costs, and increasing R&D spending threaten profit margins and future cash flow.
View narrative
US$90.84
FV
21.8% overvalued
intrinsic discount
-0.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Ciena
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Slow Data Demand And Concentrated Customers Will Undermine Outlook
Key Takeaways Ciena faces slowing growth and profit pressures due to market saturation, margin erosion from hardware commoditization, and dependence on a few large cloud customers. Geopolitical risks, supply chain uncertainty, and a shift toward lower-margin products threaten near-term revenue visibility and long-term earnings stability.
View narrative
US$66.00
FV
43.4% overvalued
intrinsic discount
9.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
Axalta Coating Systems
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
Sluggish North America Demand Will Exert Pressure Yet Unlock Value
Key Takeaways Sluggish repair volume and distributor restocking in key regions, alongside persistent destocking, could continue to weigh on Axalta's revenue and sales volumes recovery. Competitive pressures, rising input costs, and slower commercialization of innovations may constrain Axalta's ability to expand margins and sustain earnings growth.
View narrative
US$30.00
FV
2.5% overvalued
intrinsic discount
1.91%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies